Women Experience the Same Ergogenic Response to Caffeine as Men

This study aimed to determine whether 1) consumption of caffeine improves endurance cycling performance in women and 2) sex differences exist in the magnitude of the ergogenic and plasma responses to caffeine supplementation. Twenty-seven (11 women and 16 men) endurance-trained cyclists and triathle...

Full description

Saved in:
Bibliographic Details
Published inMedicine and science in sports and exercise Vol. 51; no. 6; p. 1195
Main Authors Skinner, Tina L, Desbrow, Ben, Arapova, Julia, Schaumberg, Mia A, Osborne, John, Grant, Gary D, Anoopkumar-Dukie, Shailendra, Leveritt, Michael D
Format Journal Article
LanguageEnglish
Published United States 01.06.2019
Subjects
Online AccessGet more information

Cover

Loading…
Abstract This study aimed to determine whether 1) consumption of caffeine improves endurance cycling performance in women and 2) sex differences exist in the magnitude of the ergogenic and plasma responses to caffeine supplementation. Twenty-seven (11 women and 16 men) endurance-trained cyclists and triathletes participated in this randomized, double-blind, placebo-controlled, crossover study. Participants completed an incremental exercise test to exhaustion, two familiarization trials, and two performance trials. Ninety minutes before the performance trials, participants ingested opaque capsules containing either 3 mg·kg body mass of anhydrous caffeine or a placebo. They then completed a set amount of work (75% of peak sustainable power output) in the fastest possible time. Plasma was sampled at baseline, preexercise, and postexercise for caffeine. Strict standardization and verification of diet, hydration, training volume and intensity, and contraceptive hormone phase (for women) were implemented. Performance time was significantly improved after caffeine administration in women (placebo: 3863 ± 419 s, caffeine: 3757 ± 312 s; P = 0.03) and men (placebo: 3903 ± 341 s, caffeine: 3734 ± 287 s; P < 0.001). The magnitude of performance improvement was similar for women (mean = 4.3%, 95% CI = 0.4%-8.2%) and men (4.6%, 2.3%-6.8%). Plasma caffeine concentrations were similar between sexes before exercise, but significantly greater in women after exercise (P < 0.001). Ingestion of 3 mg·kg body mass of caffeine enhanced endurance exercise performance in women. The magnitude of the performance enhancement observed in women was similar to that of men, despite significantly greater plasma caffeine concentrations after exercise in women. These results suggest that the current recommendations for caffeine intake (i.e., 3-6 mg·kg caffeine before exercise to enhance endurance performance), which are derived almost exclusively from studies on men, may also be applicable to women.
AbstractList This study aimed to determine whether 1) consumption of caffeine improves endurance cycling performance in women and 2) sex differences exist in the magnitude of the ergogenic and plasma responses to caffeine supplementation. Twenty-seven (11 women and 16 men) endurance-trained cyclists and triathletes participated in this randomized, double-blind, placebo-controlled, crossover study. Participants completed an incremental exercise test to exhaustion, two familiarization trials, and two performance trials. Ninety minutes before the performance trials, participants ingested opaque capsules containing either 3 mg·kg body mass of anhydrous caffeine or a placebo. They then completed a set amount of work (75% of peak sustainable power output) in the fastest possible time. Plasma was sampled at baseline, preexercise, and postexercise for caffeine. Strict standardization and verification of diet, hydration, training volume and intensity, and contraceptive hormone phase (for women) were implemented. Performance time was significantly improved after caffeine administration in women (placebo: 3863 ± 419 s, caffeine: 3757 ± 312 s; P = 0.03) and men (placebo: 3903 ± 341 s, caffeine: 3734 ± 287 s; P < 0.001). The magnitude of performance improvement was similar for women (mean = 4.3%, 95% CI = 0.4%-8.2%) and men (4.6%, 2.3%-6.8%). Plasma caffeine concentrations were similar between sexes before exercise, but significantly greater in women after exercise (P < 0.001). Ingestion of 3 mg·kg body mass of caffeine enhanced endurance exercise performance in women. The magnitude of the performance enhancement observed in women was similar to that of men, despite significantly greater plasma caffeine concentrations after exercise in women. These results suggest that the current recommendations for caffeine intake (i.e., 3-6 mg·kg caffeine before exercise to enhance endurance performance), which are derived almost exclusively from studies on men, may also be applicable to women.
Author Leveritt, Michael D
Skinner, Tina L
Arapova, Julia
Schaumberg, Mia A
Osborne, John
Anoopkumar-Dukie, Shailendra
Desbrow, Ben
Grant, Gary D
Author_xml – sequence: 1
  givenname: Tina L
  surname: Skinner
  fullname: Skinner, Tina L
  organization: School of Human Movement and Nutrition Sciences, The University of Queensland, Queensland, AUSTRALIA
– sequence: 2
  givenname: Ben
  surname: Desbrow
  fullname: Desbrow, Ben
  organization: Menzies Health Institute Queensland, Griffith University, Queensland, AUSTRALIA
– sequence: 3
  givenname: Julia
  surname: Arapova
  fullname: Arapova, Julia
  organization: School of Human Movement and Nutrition Sciences, The University of Queensland, Queensland, AUSTRALIA
– sequence: 4
  givenname: Mia A
  surname: Schaumberg
  fullname: Schaumberg, Mia A
  organization: School of Health and Sports Sciences, University of the Sunshine Coast, Queensland, AUSTRALIA
– sequence: 5
  givenname: John
  surname: Osborne
  fullname: Osborne, John
  organization: School of Exercise and Nutrition Sciences and Institute of Health and Biomedical Innovation, Queensland University of Technology, Queensland, AUSTRALIA
– sequence: 6
  givenname: Gary D
  surname: Grant
  fullname: Grant, Gary D
  organization: Quality Use of Medicines Network, School of Pharmacy and Pharmacology, Griffith University, Queensland, AUSTRALIA
– sequence: 7
  givenname: Shailendra
  surname: Anoopkumar-Dukie
  fullname: Anoopkumar-Dukie, Shailendra
  organization: Quality Use of Medicines Network, School of Pharmacy and Pharmacology, Griffith University, Queensland, AUSTRALIA
– sequence: 8
  givenname: Michael D
  surname: Leveritt
  fullname: Leveritt, Michael D
  organization: School of Human Movement and Nutrition Sciences, The University of Queensland, Queensland, AUSTRALIA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30629046$$D View this record in MEDLINE/PubMed
BookMark eNpNj9tKxDAURYMozkX_QCQ_0PGcpG2aJ5FSLzCDYBUfhzQ5GSs2KY2C_r0DKrhe9sOCDWvBDkMMxNgZwgpFri82bbuCf2BVFQdsjoWEDCQWM7ZI6XUvlJR4zGYSSqEhL-fs8jkOFHjzOdLUU7DE31-It2Yg3ky7uKPQW_5AaYwh7V3ktfGe-kDcJL6hcMKOvHlLdPq7S_Z03TzWt9n6_uauvlpnNgdRZFJ2FaHBvOzQo0KtvNWl9giIqjNeWm-dA-nBWlCKROXyrqykA3RCWC2W7Pznd_zoBnLbceoHM31t_0rENwU_Sjc
CitedBy_id crossref_primary_10_1111_bcp_14189
crossref_primary_10_1123_ijsnem_2021_0176
crossref_primary_10_3390_nu12123603
crossref_primary_10_1007_s00394_020_02427_6
crossref_primary_10_1007_s00421_020_04534_y
crossref_primary_10_3390_nu16111768
crossref_primary_10_1080_15502783_2024_2323919
crossref_primary_10_3390_nu11071600
crossref_primary_10_1007_s00421_023_05376_0
crossref_primary_10_3390_nu16091253
crossref_primary_10_1016_j_cophys_2019_05_009
crossref_primary_10_1038_s41598_023_40365_5
crossref_primary_10_1007_s40279_022_01685_0
crossref_primary_10_1186_s12970_021_00462_0
crossref_primary_10_1007_s00394_021_02510_6
crossref_primary_10_3390_nu16050668
crossref_primary_10_3390_biology11101498
crossref_primary_10_1007_s00394_022_02894_z
crossref_primary_10_3389_fspor_2020_574854
crossref_primary_10_1123_ijsnem_2020_0083
crossref_primary_10_3390_diagnostics11020324
crossref_primary_10_3390_nu12030741
crossref_primary_10_1007_s40279_022_01755_3
crossref_primary_10_1111_bcp_14175
crossref_primary_10_3390_medicina57080753
crossref_primary_10_3390_ijerph182312389
crossref_primary_10_3390_nu11112575
crossref_primary_10_1186_s12970_021_00421_9
crossref_primary_10_1007_s00394_019_02100_7
crossref_primary_10_3390_ijerph18115773
crossref_primary_10_3390_nu15051178
crossref_primary_10_1007_s00394_022_02988_8
crossref_primary_10_1123_ijsnem_2023_0191
crossref_primary_10_1007_s11302_023_09922_5
crossref_primary_10_3390_nu16111760
crossref_primary_10_3390_nu14194155
crossref_primary_10_1080_02701367_2023_2293121
crossref_primary_10_3390_nu13103663
crossref_primary_10_1139_apnm_2023_0208
crossref_primary_10_3390_nu11102313
crossref_primary_10_3390_genes11080933
crossref_primary_10_3390_biology11010017
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1249/MSS.0000000000001885
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
Physical Therapy
EISSN 1530-0315
ExternalDocumentID 30629046
Genre Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-ET
-~X
.-D
.3C
.55
.GJ
.L3
.XZ
.Z2
01R
0R~
1CY
1J1
2FS
354
3EH
40H
41~
4Q1
4Q2
4Q3
53G
5AM
5GY
5RE
5VS
68V
6TJ
71W
77Y
7O~
85S
9V3
A9M
AAAAV
AAAXR
AAFWJ
AAGIX
AAHPQ
AAIQE
AAJCS
AAJWC
AAMOA
AAMTA
AAQKA
AAQQT
AARTV
AASCR
AASOK
AAUEB
AAWTL
AAXQO
AAYJJ
ABASU
ABBUW
ABDIG
ABJNI
ABTAH
ABVCZ
ABXVJ
ABZAD
ACCJW
ACDDN
ACEWG
ACGFO
ACGFS
ACIFK
ACILI
ACJBD
ACNCT
ACTHT
ACWDW
ACWRI
ACXJB
ACXNZ
ADBIZ
ADEGP
ADFPA
ADGGA
ADHPY
ADNKB
ADNVM
AE3
AE6
AEBDS
AEETU
AENEX
AFDAS
AFDTB
AFEXH
AFFDN
AFFNX
AFHKK
AFMIJ
AFSOK
AFUWQ
AFYGQ
AGINI
AHOMT
AHQNM
AHRYX
AHVBC
AHWXW
AIDAL
AIJEX
AINUH
AJEOO
AJIOK
AJNWD
AJNYG
AKULP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
ATPOU
AWKKM
BOYCO
BQLVK
BS7
C45
CGR
CS3
CUY
CVF
DIWNM
DU5
DUNZO
E.X
EBS
ECM
EEVPB
EIF
EJD
ERAAH
EX3
F2K
F2L
F2M
F2N
F5P
FCALG
FL-
FRP
FW0
G8K
GNXGY
GQDEL
H0~
HLJTE
HZ~
H~9
IKREB
IKYAY
IN~
IYOWL
JF9
JG8
JK3
JK8
K8S
KD2
KMI
L-C
MMDCI
MPPUT
MVM
N4W
NEJ
NHB
NPM
N~6
N~7
N~B
N~M
O9-
OAG
OAH
OBZCC
OCUKA
ODA
ODMTH
OGKNY
OHH
OHT
OHYEH
OJAPA
OKBHI
OL1
OLG
OLH
OLL
OLU
OLV
OLW
OLY
OLZ
OPUJH
OPX
ORVUJ
OUVQU
OVD
OVDLW
OVDNE
OVIDH
OVLEI
OVOZU
OWU
OWV
OWW
OWX
OWY
OWZ
OXXIT
P-K
P2P
QMB
QZG
R2J
R58
RLZ
S4R
S4S
SJN
T8P
TEORI
TN5
TSPGW
TWZ
UAP
UKR
V2I
VJK
VVN
W3M
WF8
WH7
WOQ
WOW
X3V
X3W
X7M
XFK
XJT
XOL
XXN
XYM
XZL
YCJ
YFH
YNT
YOC
YOJ
YQT
YYQ
ZB8
ZCA
ZCG
ZFV
ZGI
ZHY
ZKB
ZUP
ZXP
ZY4
ZZMQN
~02
ID FETCH-LOGICAL-c4025-33b8e1a146b1f17197fc969f10117baf3cfcdd03f0cc077e28d4b683d01d22c92
IngestDate Thu May 23 23:47:10 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c4025-33b8e1a146b1f17197fc969f10117baf3cfcdd03f0cc077e28d4b683d01d22c92
OpenAccessLink https://doi.org/10.1249/mss.0000000000001885
PMID 30629046
ParticipantIDs pubmed_primary_30629046
PublicationCentury 2000
PublicationDate 2019-06-00
PublicationDateYYYYMMDD 2019-06-01
PublicationDate_xml – month: 06
  year: 2019
  text: 2019-06-00
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Medicine and science in sports and exercise
PublicationTitleAlternate Med Sci Sports Exerc
PublicationYear 2019
SSID ssj0007331
Score 2.5124493
Snippet This study aimed to determine whether 1) consumption of caffeine improves endurance cycling performance in women and 2) sex differences exist in the magnitude...
SourceID pubmed
SourceType Index Database
StartPage 1195
SubjectTerms Adult
Bicycling - physiology
Body Mass Index
Caffeine - administration & dosage
Caffeine - blood
Central Nervous System Stimulants - administration & dosage
Central Nervous System Stimulants - blood
Cross-Over Studies
Double-Blind Method
Female
Heart Rate - physiology
Humans
Male
Performance-Enhancing Substances - administration & dosage
Performance-Enhancing Substances - blood
Physical Endurance - physiology
Sex Factors
Young Adult
Title Women Experience the Same Ergogenic Response to Caffeine as Men
URI https://www.ncbi.nlm.nih.gov/pubmed/30629046
Volume 51
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NT8IwFG9AE8LF7--P9ODNDNdtbN3JoNEYE4wJmHAjbdcqBwYR4sGDf7uvXTtQ0agcFtLCsvT32-t7r-8DoZOEcq79-17oy8yL4lB4-vQFbJ4MlOs4Skmk853bd_HNQ3Tba_Yqlbf57JIpb4jXhXkl_0EVxgBXnSX7B2TLm8IAfAd84QoIw_VXGJv2k3PVio0W2WFDCeLtcQR_M1HyJgjWdMi4ZEpJrVayiQ5nnVdM2_aM3RwmuFyfQX46KY4U9KjrzlQ6ZWZ9u7qDnJ2WbmSwZbmt7HgxyzRrPbPx6IW5pOxyO-iIJ2bakjwWYfzMuletK0JnP7mQqYZ04tP3dN-IeflqC8oOvghLXW1uoRQHkxCWvt3pFNUl7YdQ-uHngMV4aJAFsydI_cKV-fPsp9rabqqKqgnV8vFO-3rsPq67WdpkS3igs0WPU0c1d4tPZolRT7praMXaFbhVkGQdVWS-gWoO1Q20em9fSNwt6khsonNDHzyjDwb6YE0fXNIHO_rg6Qg7-mA2wUCfLfRwfdW9vPFsPw1PRLprcRhyKgmDvZETRRKSJkqkcaqIrgvImQqFElnmh8oXwk8SGdAs4jENM59kQSDSYBst5aNc7iIsm7KZEsoUEVEU-oLFsVBNGQRUqDQLyB7aKVajPy6KpvTdOu1_O3OA6jNSHaJlBW-pPAKVb8qPDTLvTj1RIQ
link.rule.ids 786
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Women+Experience+the+Same+Ergogenic+Response+to+Caffeine+as+Men&rft.jtitle=Medicine+and+science+in+sports+and+exercise&rft.au=Skinner%2C+Tina+L&rft.au=Desbrow%2C+Ben&rft.au=Arapova%2C+Julia&rft.au=Schaumberg%2C+Mia+A&rft.date=2019-06-01&rft.eissn=1530-0315&rft.volume=51&rft.issue=6&rft.spage=1195&rft_id=info:doi/10.1249%2FMSS.0000000000001885&rft_id=info%3Apmid%2F30629046&rft_id=info%3Apmid%2F30629046&rft.externalDocID=30629046